TNFRSF17 and Miyoshi myopathy: Regarding antigen loss, while the initial results from anti-BCMA CAR-T cell trials have been encouraging, biallelic deletion of the BCMA locus has been described as a mechanism of BCMA loss in MM patients treated with CAR-T cells19,20.